(Q44362302)

English

Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34(+) cells and a fixed CD3(+) dose

scientific article published on 26 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34(+) cells and a fixed CD3(+) dose (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

C C Dvorak

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A L Gilman

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

B Horn

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

C-Y Oon

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

E A Dunn

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

L A Baxter-Lowe

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M J Cowan

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

26 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

508-513

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Infusion of cytomegalovirus specific cytotoxic T lymphocytes from a sero-negative donor can facilitate resolution of infection and immune reconstitution.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Long-term outcome after haploidentical stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

21 January 2018

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

7 January 2021

based on heuristic

inferred from DOI database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohematologic reconstitution in pediatric patients after T cell-depleted HLA-haploidentical stem cell transplantation for thalassemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

7 January 2021

based on heuristic

inferred from DOI database lookup

High rabbit-antihuman thymocyte globulin levels are associated with low likelihood of graft-vs-host disease and high likelihood of posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.186

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2012.186

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dimensions Publication ID

0 references

release_6t2cbpuifzep7eiswgcxh6ae6i

1 reference

https://api.fatcat.wiki/v0/release/6t2cbpuifzep7eiswgcxh6ae6i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44362302&oldid=2206591841"